Related Experiment Video
Updated: Jul 19, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
LncRNA DGCR5-encoded polypeptide RIP aggravates SONFH by repressing nuclear localization of β-catenin in BMSCs
Weiqian Jiang1, Yu Chen1, Mingjie Sun1
1Department of Orthopedics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Abstract:
The differentiation fate of bone marrow mesenchymal stem cells (BMSCs) affects the progression of steroid-induced osteonecrosis of the femoral head (SONFH). We find that lncRNA DGCR5 encodes a 102-amino acid polypeptide, RIP (Rac1 inactivated peptide), which promotes the adipogenic differentiation of BMSCs and aggravates the progression of SONFH. RIP, instead of lncRNA DGCR5, binds to the N-terminal motif of RAC1, and inactivates the RAC1/PAK1 cascade, resulting in decreased Ser675 phosphorylation of β-catenin. Ultimately, the nuclear localization of β-catenin decreases, and the differentiation balance of BMSCs tilts toward the adipogenesis lineage. In the femoral head of rats, overexpression of RIP causes trabecular bone disorder and adipocyte accumulation, which can be rescued by overexpressing RAC1. This finding expands the regulatory role of lncRNAs in BMSCs and suggests RIP as a potential therapeutic target.
Insights
A novel peptide, RIP, derived from lncRNA DGCR5, promotes bone marrow mesenchymal stem cell (BMSC) adipogenesis and worsens steroid-induced osteonecrosis of the femoral head (SONFH). Targeting RIP may offer a therapeutic strategy for SONFH.
Area of Science:
- Molecular Biology
- Stem Cell Biology
- Orthopedics
Background:
- Steroid-induced osteonecrosis of the femoral head (SONFH) progression is linked to bone marrow mesenchymal stem cell (BMSC) differentiation.
- Long non-coding RNAs (lncRNAs) play roles in cellular differentiation, but their specific functions in SONFH are not fully understood.
Purpose of the Study:
- To investigate the role of lncRNA DGCR5 and its encoded peptide in BMSC differentiation and SONFH pathogenesis.
- To identify potential therapeutic targets for SONFH.
Main Methods:
- In vitro studies on BMSC differentiation.
- Molecular mechanism analysis involving RIP, RAC1, PAK1, and β-catenin.
- In vivo experiments using a rat model of SONFH.
Main Results:
- lncRNA DGCR5 encodes a polypeptide named RIP (Rac1 inactivated peptide).
- RIP promotes BMSC adipogenic differentiation and exacerbates SONFH.
- RIP inactivates the RAC1/PAK1 cascade by binding to RAC1, reducing β-catenin phosphorylation and nuclear localization.
- Overexpression of RIP in rats led to bone disorder and adipocyte accumulation, which was reversed by RAC1 overexpression.
Conclusions:
- RIP, a peptide encoded by lncRNA DGCR5, drives BMSC adipogenesis and worsens SONFH by inhibiting the RAC1/PAK1/β-catenin pathway.
- RIP represents a potential therapeutic target for managing steroid-induced osteonecrosis of the femoral head.
More Related Videos
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
07:14Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
Related Concept Videos
lncRNA - Long Non-coding RNAs
Regulation of Nuclear Protein Sorting
Canonical Wnt Signaling Pathway
Nuclear Localization Signals and Import
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Co-activators and Co-repressors